|Source||Humanized (from mouse)|
|Mol. mass||77.3 kDa|
| (what is this?)
Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, an ribosome inactivating protein from the plant Bougainvillea spectabilis. It has undergone pre-clinical trials for the treatment of ovarian cancer and other solid tumors.
- International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
- Viventia Biotech Inc.: VB6-845
|This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|